Hotchkis & Wiley Capital Management’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
Hotchkis & Wiley Capital Management's ASTH Position: Q2 2026 in Review
Hotchkis & Wiley Capital Management reduced its Astrana Health (ASTH) stake by 48% in Q2 2026, selling an estimated $8.35M and leaving 249,410 shares worth $11.6M. The position accounts for 0.03% of the portfolio, ranked #241.
Hotchkis & Wiley Capital Management first reported a position in ASTH in Q1 2025 and has held it in 6 quarters since. The position peaked at $12M in Q3 2025. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- Hotchkis & Wiley Capital Management held 249,410 shares of Astrana Health worth $11.6M as of Q2 2026.
- Hotchkis & Wiley Capital Management sold 232,110 Astrana Health shares in Q2 2026, an estimated $8.35M.
- Astrana Health made up 0.03% of Hotchkis & Wiley Capital Management's portfolio in Q2 2026, its #241 holding.
- Hotchkis & Wiley Capital Management first reported a position in Astrana Health in Q1 2025 and has held it in 6 quarters since.
- Hotchkis & Wiley Capital Management's Astrana Health position peaked at $12M in Q3 2025.
- 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on Hotchkis & Wiley Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.